Board Review Day 1 - Diabetes and Hypoglycemia

Thursday, May 12, 2022

3:00 PM – 4:00 PM

Location: Breakout Room 3- Sapphire 400 AB (Level 4)

Speaker(s)

Archana Sadhu, MD, FACE
Director, System Diabetes Program and Director, Transplant Endocrinology
Houston Methodist
Houston, TX, United States

Disclosure: Abbott (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing)

PDF Slides
Viral N. Shah, MD
Associate Professor
Barbara Davis Center for Diabetes, University of Colorado
Aurora, Colorado, United States

Disclosure: Dexcom (Self) : Research Grant (Status: Ongoing); Eli-Lilly (Self) : Grant/Research Support (Status: Ongoing); Insulet (Self) : Grant/Research Support (Status: Ongoing); Medscape LLC (Self) : Consulting Fees (e.g., advisory boards) (Status: Ongoing); Novo Nordisk (Self) : Grant/Research Support (Status: Ongoing); Sanofi (Self) : Consulting Fees (e.g., advisory boards) (Status: Terminated --- ); Tandem Diabetes Care (Self) : Research Grant (Status: Ongoing)

Moderator(s)

Joumana T. Chaiban, MD, MBA, FACE
Associate Professor of Clinical Medicine
University of Illinois at Chicago/Advocate Christ Medical Center
Chicago, Illinois, United States

Disclosure: Doximity (Self) : Ownership Interest (Status: Ongoing)

Welcome by AACE Self-Assessment Program Chair, Elias S. Siraj, MD, Dr. Med., FACP, FACE

Learning Objectives:

Review indications and mechanism of actions of newer classes of agents for type 2 diabetes
Identify rare causes of endogenous hyperinsulinemia hypoglycemia
Manage complications of insulin therapy such as hypoglycemia and injection related site skin changes

Participants should be aware of the following financial/non-financial relationships:

Archana Sadhu, MD, FACE: Abbott (Individual(s) Involved: Self): Consulting Fees (e.g., advisory boards)

Viral N. Shah, MD: Dexcom (Individual(s) Involved: Self): Research Grant; Eli-Lilly (Individual(s) Involved: Self): Grant/Research Support; Insulet (Individual(s) Involved: Self): Grant/Research Support; Medscape LLC (Individual(s) Involved: Self): Consulting Fees (e.g., advisory boards); Novo Nordisk (Individual(s) Involved: Self): Grant/Research Support; Sanofi (Individual(s) Involved: Self): Consulting Fees (e.g., advisory boards); Tandem Diabetes Care (Individual(s) Involved: Self): Research Grant

Joumana T. Chaiban, MD, MBA, FACE: Doximity (Individual(s) Involved: Self): Ownership Interest